Skip to main content

Animations

MJFF Publications

721 - 730 of 8142 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • RESTRICTED
    Title: Strategies for quantifying the enzymatic activities of glycoside hydrolases within cells and in vivo
    Journal Name: Current Opinion in Chemical Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.cbpa.2023.102403
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: The Michael J. Fox Foundation's quest for a cure for Parkinson's disease: an interview with Nicole Polinski
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1242/dmm.050605
    Citation Count: 0
  • OPEN
    Title: Challenges and innovations in brain PET analysis of neurodegenerative disorders: a mini-review on partial volume effects, small brain region studies, and reference region selection
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2023.1293847
    Citation Count: 4
  • OPEN
    Title: Regulation of expression quantitative trait loci by SVA retrotransposons within the major histocompatibility complex
    Journal Name: Experimental Biology and Medicine
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/15353702231209411
    Citation Count: 6
  • RESTRICTED
    Title: Examining the association between posttraumatic stress disorder and disruptions in cortical networks identified using data-driven methods
    Journal Name: Neuropsychopharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41386-023-01763-5
    Best OA location URL:
    Citation Count: 1
  • OPEN
    Title: Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase dependent mechanism
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.91083
    Citation Count: 1
  • RESTRICTED
    Title: Genetics of Parkinson's disease heterogeneity: A genome-wide association study of clinical subtypes
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105935
    Best OA location URL:
    Citation Count: 1
  • OPEN
    Title: Cell-free RNA signatures predict Alzheimer’s disease
    Journal Name: iScience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.isci.2023.108534
    Citation Count: 4
  • OPEN
    Title: Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.91645.2
    Citation Count: 25
  • OPEN
    Title: Co‐Existent Probable RBD and PD: Disease Progression, Medication Response, and Clinical Trial Implications
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.13890
    Best OA location URL:
    Citation Count: 1
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.